- Home
- PLMR vs RGC Comparison
PLMR vs RGC Comparison
Compare PLMR & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLMR | RGC |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.1B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PLMR | RGC |
|---|---|---|
| Price | $136.68 | $7.05 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $153.60 | N/A |
| AVG Volume (30 Days) | ★ 177.5K | 149.4K |
| Earning Date | 05-06-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.04 | N/A |
| EPS | ★ 3.51 | N/A |
| Revenue | ★ $875,967,000.00 | N/A |
| Revenue This Year | $192.25 | N/A |
| Revenue Next Year | $19.34 | N/A |
| P/E Ratio | $38.70 | ★ N/A |
| Revenue Growth | ★ 58.16 | N/A |
| 52 Week Low | $100.81 | $4.51 |
| 52 Week High | $147.62 | $69.00 |
Technical Indicators
Market Signals| Indicator | PLMR | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 57.37 | 60.05 |
| Support Level | $116.49 | $4.71 |
| Resistance Level | $140.88 | $6.75 |
| Average True Range (ATR) | 3.54 | 0.45 |
| MACD | 0.51 | 0.25 |
| Stochastic Oscillator | 95.92 | 85.56 |
Price Performance
Historical ComparisonAbout PLMR Palomar Holdings Inc.
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. It provides insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The company's Earthquake product generate high premium.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.